Part of this can be mediated via induction of SGK1 by glucocorticoids, and indeed the insulin effect on NHE3 can also be amplified by overexpression of SGK1. We next addressed the acute effect of insulin (1-2 h) on NHE3 by systematically examining the candidate signaling cascades and activation mechanisms of NHE3. We ruled out the PI3K-SGK1-Akt and TC10 pathways, increased surface NHE3, NHE3 phosphorylation, NHE3 association with calcineurin homologous protein 1 or megalin as mechanisms of acute activation of NHE3 by insulin. In summary, insulin stimulates NHE3 acutely via yet undefined pathways and mechanisms. The chronic effect of insulin is mediated by the classic PI3K-SGK1 route.
Chronic insulin (24 h) activates NHE3 through the classic phosphatidylinositol 3-kinase-serum-and glucocorticoid-dependent kinase 1 (PI3K-SGK1) pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the PI3K inhibitor wortmannin or a dominant-negative SGK1. We showed that SGK1 transcript and protein are expressed in rat proximal tubule and OK cells. We previously showed that glucocorticoids augment the effect of insulin on NHE3 ( Part of this can be mediated via induction of SGK1 by glucocorticoids, and indeed the insulin effect on NHE3 can also be amplified by overexpression of SGK1. We next addressed the acute effect of insulin (1-2 h) on NHE3 by systematically examining the candidate signaling cascades and activation mechanisms of NHE3. We ruled out the PI3K-SGK1-Akt and TC10 pathways, increased surface NHE3, NHE3 phosphorylation, NHE3 association with calcineurin homologous protein 1 or megalin as mechanisms of acute activation of NHE3 by insulin. In summary, insulin stimulates NHE3 acutely via yet undefined pathways and mechanisms. The chronic effect of insulin is mediated by the classic PI3K-SGK1 route. Na ϩ /H ϩ exchanger isoform 3; serum-and glucocorticoid-dependent kinase 1 INSULIN HAS MYRIAD EFFECTS on multiple organs and cell types. Although insulin receptors are believed to be widely expressed in the kidney (9, 44, 45, 53) , the renal actions of insulin are not well understood. One classic insulin effect on the kidney concerns glucose homeostasis. While the antigluconeogenic action of insulin on the kidney appears to be well established (28, 39) , the quantitative role of the kidney in whole-body gluconeogenesis is still a matter of some controversy (14, 22) . In addition to gluconeogenesis, insulin is known to alter glomerular filtration rate, sodium excretion, phosphate excretion, and ammonium excretion, although the data supporting some of these effects are not always uniform (17, 32, 33, 52) .
In the renal proximal tubule, insulin has been described to stimulate fluid volume absorption (4) and ammonia synthesis and excretion (17, 32) in addition to its antigluconeogenic effects. One protein poised along the pathways of Na ϩ as well as acid-base homeostasis is the proximal tubule apical membrane Na ϩ /H ϩ exchanger isoform 3 (NHE3). In addition to NaCl (49) and NaHCO 3 (48) absorption, apical Na ϩ /H ϩ exchange also mediates the secretion of ammonium into the tubular lumen (43) . Insulin has been shown to stimulate ammoniagenic enzymes and proximal tubule Na ϩ /H ϩ exchange in suspended tubules (4) and in cultured proximal tubule-like cells (31) . Na ϩ /H ϩ exchangers are transmembrane proteins ubiquitous in the animal and plant kingdom (46) . In mammals, they mediate electroneutral exchange of Na ϩ for H ϩ . Nine mammalian isoforms have been identified which represent nine paralogs (11) . Although more than one NHE isoform may mediate Na ϩ transport in the proximal tubule (23), NHE3 is the predominant and best studied isoform responsible for proximal Na ϩ absorption based on both antigenic and functional data (3, 18, 55, 56, 59) . The importance of NHE3 in Na ϩ and acid-base homeostasis is exemplified by the hypovolemic hypotension and metabolic acidosis seen in NHE3 Ϫ/Ϫ mice despite compensation by the distal nephron (51). NHE3 can be regulated through a wide array of mechanisms, ranging from transcription, translation, protein trafficking, protein phosphorylation, and association with regulatory proteins.
The insulin receptor signals through a variety of intracellular cascades; one of the best studied pathways involves the insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase (PI3K)-PI3K-dependent kinase (PDK)-serum-and glucocorticoid-dependent kinase 1 (SGK1) axis (36, 47) . There is evidence to suggest that the nongenomic effect of glucocorticoids may act via SGK1 (61) . How insulin signals NHE3 stimulation is not known. We previously showed that the stimulatory effect of insulin on NHE3 is amplified by glucocorticoids and associated with changes in NHE3 protein and transcript levels with a complex multiphasic profile (31) . In the early phase of stimulation, insulin increases NHE3 activity without changes in NHE3 protein and mRNA. At 24 h, enhanced NHE3 activity is accompanied by an increase in NHE3 protein and mRNA abundance (31) . It is therefore likely that the acute and chronic stimulation of NHE3 by insulin occurs via the activation of distinct signaling pathways. In this paper, we used the marsupial epithelial cell line [opossum kidney (OK) cells], which possesses numerous characteristics of the mammalian proximal tubule, to define the mechanism of stimulation of NHE3 activity, dependence on glucocorticoids, and insulin signaling pathways.
EXPERIMENTAL PROCEDURES
Cell culture, transfection, and reagents. OK cells (19) cultured at 37°C in 95% air/5% CO 2 atmosphere were passed in high-glucose (4.5 g/l) DMEM supplemented with 10% (vol/vol) fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 g/ml). Cells were rendered quiescent postconfluence by serum removal for 48 h before the experiments. Transient transfections were performed with Lipofectamine Plus (Invitrogen, Carlsbad, CA), and efficiency was assessed by cotransfection with enhanced green fluorescent protein (eGFP) and monitoring of cells with fluorescent microscopy (typically Ͼ80% positive). Mammalian expression plasmids and inserts included COOH-terminal c-myc-and hexahistidine (His 6)-tagged opossum NHE3 (NHE3/myc/6H) in pcDNA3.1 (Invitrogen); COOH-terminal human influenza hemagglutinin (HA)-tagged mouse calcineurin homologous protein 1 (CHP1) in pMH (Roche, Indianapolis, IN); untagged wild-type mouse SGK1 and kinase-dead dominant-negative (K127M) mouse SGK1 in pcDNA3.1; triple NH 2-terminal HA-tagged constitutively active (Q67L) and dominant-negative (T23N) TC10 in pKH3 (16) ; and untagged wild-type and dominant-negative (K179M) Akt in pcDNA3.1. The SGK1 constructs were a gift from D. Pearce, UCSF (San Francisco, CA). The TC10 constructs were a gift from A. Saltiel (University of Michigan, Ann Arbor, MI). The rat receptorassociated protein (RAP)-glutathione S-transferase (GST) fusion construct in the plasmid pGEX-DGRAP was a gift from J. Herz (University of Texas Southwestern Medical Center, Dallas, TX) (26) . Rabbit anti-human SGK1 antibody was obtained from Genex Bioscience (Hayward, CA), and anti-human phosphoserine 78 SGK1 and rabbit anti-mouse phosphoserine 473 Akt antibodies were purchased from Cell Signaling (Beverly, MA). Streptavidin beads were obtained from Pierce (Rockford, IL), and protein G-agarose from Calbiochem (San Diego, CA). Unless otherwise specified, all reagents were from Sigma (St. Louis, MO).
Cloning of opossum SGK1. Total OK cell RNA was isolated using guanidium thiocyanate and acid phenol extraction. OK cell cDNA was prepared by oligo-dT-primed reverse transcription using the Thermoscript method (Invitrogen). Opossum (Didelphis virginiana) SGK1 ORF was cloned by PCR from OK cell cDNA using degenerate primers (forward 5Ј-ATGACSGTSAAARCYGAGGCT-3Ј; reverse 5Ј-TCAGAGGAARGARTCCRYRGG-3Ј) and verified by sequencing. For RNA blotting, total OK cell RNA was size-fractionated by formaldehyde gel electrophoresis, transferred to nitrocellulose membranes, and probed with random-primed 32 P-uniformly labeled opossum SGK1 cDNA under high-stringency conditions. 18S cDNA was used in sequential probing to control for loading.
Single-tubule microdissection and RT-PCR. Rat proximal straight tubules (PST), proximal convoluted tubules (PCT), and cortical collecting ducts (CCD) were dissected as described previously (5) . Total RNA from microdissected tubules was prepared using a Microprep kit from Stratagene (La Jolla, CA), and cDNA was obtained by oligodT-primed reverse transcription using the Thermoscript method. The following primers were used for PCR: SGK1 forward 5Ј-ATGAC-CGTCAAAACCGAGGCT-3Ј; reverse 5Ј-TCAGAGGAAGGAGTC-CATAGG-3Ј and NHE3 forward 5Ј-ATGACCGTCAAAACCGAG-GCT-3Ј; reverse 5Ј-TCAGAGGAAGGAGTCCATAGG-3Ј.
Immunocytochemistry and immunohistochemistry. For immunocytochemistry, OK cells were fixed in 4% paraformaldehyde in PBS for 10 min, permeabilized in 0.1% Triton X-100 in PBS for 3 min, and blocked by 5% bovine serum albumin in PBS at 37°C for 1 h. Specimens were incubated with rabbit anti-human SGK1 polyclonal antibody (1:200 dilution), followed by FITC-conjugated donkey antirabbit antibody (Jackson ImmunoResearch Laboratories, West Grove, PA) and rhodamine-conjugated phalloidin (1:50 dilution, Invitrogen). Confocal fluorescent images were visualized through a Zeiss ϫ100 objective lens using a Zeiss LSM-410 laser-scanning confocal microscope. Rhodamine and FITC fluorescence were detected using excitation laser wavelengths (in nm) of 568 and 488 and emission filters of 590 long-pass, 510 -560 band-pass, and 670 -810 band-pass, respectively.
For immunohistochemistry, anesthetized Sprague-Dawley rats were fixed by retrograde perfusion through the abdominal aorta with a solution of 2% paraformaldehyde in PBS. All animal protocols were approved by the Institutional Animal Care and Use Committee. Kidneys were sliced and further fixed for 1 h in 2% paraformaldehyde followed by 1 h in a cryoprotectant of 10% EDTA in 0.1 M Tris and frozen as previously described (54) . Cryostat sections 8-m thick were picked up on coverslips coated with HistoGrip (Zymed, San Francisco, CA). Sections were then treated with 0.5% SDS for 10 min to unmask antigenic sites (12) . Sections washed three times with high-salt buffer (50 ml PBS, 0.5 g BSA, 1.13 g NaCl) and incubated in blocking agent (50 ml PBS, 0.5 g BSA, 0.188 g glycine, pH 7.2) for 20 min, followed by incubation with a primary antibody overnight at 4°C. Primary antibodies (anti-SGK1, Upstate Biotechnology) were diluted to 10 g/ml with incubation medium (50 ml PBS, 0.05 g BSA, 200 l 5% NaN 3). Specificity of labeling was demonstrated by inclusion of an immunogenic peptide (amino acids 399 -412 of human SGK1, GKSPDSVLVTASVK) at 5 g/ml. After this incubation, sections were rinsed five times with high-salt buffer over the course of 1 h. Appropriate species-specific secondary antibodies coupled to Alexa 488 or 568 dyes (Molecular Probes, Eugene, OR) were diluted 1:200 with incubation medium and then incubated with the tissue sections for 2 h at 4°C, washed as above, and mounted for confocal microscopy. Confocal microscopy was performed as described above.
NHE3 activity assay. NHE3 activity was measured fluorometrically using the intracellularly trapped pH-sensitive dye BCECF as described previously (42) . Cells grown on glass coverslips were loaded with 10 M BCECF-AM (30 min at 37°C) and intracellular pH (pH i) was estimated from the ratio of fluorescence ( excitation: 500 and 450 nm, emission: 530 nm) in a computer-controlled spectrofluorometer (QM-8/2003, Photon Technology International, London, Ontario). The 500/450-nm fluorescence ratio was calibrated to pH i using K ϩ /nigericin as described (27) . Na ϩ /H ϩ exchange activity was assayed as the initial rate of the Na ϩ -dependent pHi increase after an acid load using nigericin in the absence of CO 2/HCO3 Ϫ (dpHi/dt). Comparisons were always made between cells of the same passage studied on the same day. Intracellular buffer capacity (␤) was measured by pulsing cells with 20 mM NH 4Cl, according to the formula ␤ ϭ [NH 4Cl]/⌬pHi. ␤ values for control and treated cells were not significantly different (not shown).
Coimmunoprecipitation experiments in OK cells. Confluent quiescent OK cells were treated with either vehicle or agonist. After being washed with PBS, cells were lysed with ice-cold RIPA buffer [in mM: 150 NaCl, 50 Tris ⅐ HCl, pH 8.0, 5 EDTA, and 1 EGTA as well as 1% Triton X-100 (vol/vol) and protease inhibitor cocktail from Roche]. The slurry was cleared by centrifugation (109,000 g max at 50,000 rpm; 30 min; 4°C; Beckman TLA 100.3 rotor), and NHE3 was precipitated with primary antiserum (NHE3 5683) at 1:200 dilution and protein G-agarose. The polyclonal NHE3 antibody (5683) has been described previously (58) . After being washed with RIPA buffer, the antibodyantigen complex was eluted in SDS buffer [5 mM Tris ⅐ HCl, pH 6.8, 10% glycerol (vol/vol), 1% ␤-mercaptoethanol (wt/vol), 0.1% SDS (wt/vol), 0.01% bromophenol blue (wt/vol)], resolved by SDS-PAGE, and transferred to a polyvinylidene fluoride (PVDF) membrane. Immunoblotting was performed with the appropriate antisera at a 1:1,000 dilution and developed using enhanced chemiluminescence (Amersham, Pittsburgh, PA).
NHE3 phosphorylation and tryptic phosphopeptide mapping.
NHE3 phosphorylation and tryptic phosphopeptide mapping were performed in intact cells as described previously (62) . After incubation in phosphate-free DMEM, cells were loaded with [ 32 P]orthophosphate (200 -330 Ci/ml; 120 min), and insulin, hydrocortisone, or vehicle was added for 120 min. After being washed with ice-cold TBS, cells were lysed with ice-cold phospho-RIPA buffer [in mM: 150 NaCl, 80 NaF, 50 Tris ⅐ HCl, pH 8.0, 5 EDTA, 1 EGTA, 25 Na-pyrophosphate, and 1 Na-orthovanadate as well as 1% Nonidet P-40 (vol/vol), 0.5% deoxycholate (wt/vol), 0.1% SDS (wt/vol), and protease inhibitor cocktail]. The slurry was cleared by centrifugation at 109,000 gmax. NHE3 immunoprecipitation and immunoblotting were performed as described above.
32 P content was visualized by autoradiography.
For tryptic phosphopeptide mapping, acrylamide membrane pieces containing NHE3 protein were localized by autoradiography, excised, and incubated in 100 mM acetic acid containing 0.5% polyvinylpyrrolidone (wt/vol) at 37°C for 45 min. After being washed with deionized water and 0.05% NH4HCO3 solution, membranes were incubated in 15 g N-tyrosyl-L-phenylalanine chloromethyl-ketonetreated trypsin (Worthington, Lakewood, NJ) in 300 l of 0.05% NH4HCO3 solution in a 37°C shaking water bath. Fifteen micrograms of N-tyrosyl-L-phenylalanine chloromethyl-ketone-treated trypsin were added after 2 and 12 h. After repeated deionized water washes and lyophilization, the dried samples were resuspended in 20 l of electrophoresis buffer [per liter: 25 ml of 88% formic acid (wt/vol), 78 ml of glacial acetic acid, 897 ml of deionized water, pH 1.95], spotted on a cellulose TLC plate (Merck, Darmstadt, Germany), and electrophoresis was performed on a Hunter thin-layer electrophoresis apparatus with the above buffer (30 min; 1.0 kV). Separation of the peptides in the second dimension was achieved by ascending chromatography [375:250:75:300 n-butanol, pyridine, glacial acetic acid, deionized water (wt/vol)]. The phosphopeptides were visualized by autoradiography.
Determination of surface free and megalin-associated NHE3 fractions. Total cell surface NHE3 and cell surface megalin-associated NHE3 were determined simultaneously on the same culture dishes after treatment with insulin or vehicle for the stated time. Total cell surface NHE3 was determined by a conventional biotinylation assay as described earlier (10) . To quantify cell surface megalin-associated NHE3, we used glutathione-S-transferase-receptor-associated protein (GST-RAP) pulldown of cell surface megalin. RAP binds megalin with high affinity, and GST-RAP has been previously used to purify and quantify megalin from both cultured cells and kidney tissue (13, 20, 63) . We employed GST-RAP to coprecipitate megalin-associated NHE3. GST-RAP was prepared as described previously (26) . Cells were incubated for 1 h with GST-RAP at 4°C to minimize internalization. GST-RAP-megalin complexes were precipitated using glutathionine beads, yielding the megalin-associated surface NHE3 fraction. The remaining supernatant was used for precipitation with streptavidin beads, constituting the non-megalin-associated surface NHE3 fraction. GST-RAP-megalin-NHE3 and streptavidin-NHE3 were eluted in SDS buffer, resolved by SDS-PAGE, and transferred to PVDF membranes as described above. Immunoblotting was performed as described above.
RESULTS

Signaling pathway for the chronic effect of insulin on NHE3.
We previously showed that chronic treatment (24 h) with insulin increases NHE3 activity and NHE3 protein (31) . A well-established insulin-signaling cascade is the PI3K-SGK1 pathway (36, 47) . Inhibition of PI3K by wortmannin did not affect baseline NHE3 activity but blocked the stimulation of NHE3 by insulin (Fig. 1A) . Transfection of a kinase-dead dominant-negative SGK1 reduced the insulin stimulation of NHE3 activity, while transfection of wild-type SGK1 amplified the insulin stimulation (Fig. 1B) . Neither wild-type nor dominant-negative SGK1 affected baseline NHE3 activity. Unfortunately, several attempts for small-interference RNA knockdown of endogenous SGK1 in OK cells were unsuccessful and yielded only minimal (Ͻ30%) reduction in SGK1 protein levels (data not shown). Akt is another possible pathway downstream from PI3K. Dominant-negative Akt had no effect on the chronic stimulation of NHE3 by insulin (data not shown).
Expression of SGK1 in renal proximal tubule and proximal tubule-like cell line. We detected SGK1 protein in kidney sections under baseline conditions without exogenous steroid administration ( Fig. 2A) . SGK1 colocalized with NHE3 in the proximal tubule, and excess immunizing SGK1 peptide blocked the signal (Fig. 2A) . OK cells, which possess numerous characteristics of the mammalian proximal tubule, also express endogenous SGK1 (Fig. 2B) . In addition, the SGK1 transcript was present in microdissected proximal tubules by RT-PCR (Fig. 2C) . Microdissection precision was assured by coamplification of NHE3 in PST and PCT and its absence in . A: opossum kidney (OK) cells were pretreated with wortmannin (10 Ϫ7 M) or vehicle and then subjected to 10 Ϫ7 M insulin for 24 h. B: OK cells were transfected with either wild-type serum-and glucocorticoid-dependent kinase 1 (SGK1) or kinase-dead K127M SGK1, which functioned as a dominant-negative, and then subjected to 10 Ϫ7 M insulin or vehicle for 24 h. For all of the above experiments, NHE3 activity was measured fluorometrically as Na ϩ -dependent cell pH recovery after an acid load. Bars and error bars represent means and SE, respectively, from independent experiments (n ϭ 15 for each condition). Statistical significance of differences was assessed by ANOVA (*P Ͻ 0.05).
the CCD. Opossum SGK1 cDNA shares a high similarity to mouse and human SGK1 (Fig. 3A) . SGK1 transcript and protein were detected by RNA blotting (Fig. 3B ) and immunoblotting (Fig. 3C) , respectively, with a polyclonal antibody recognizing the 13 most COOH-terminal amino acids of human SGK1, which are highly conserved in opossum SGK1 (Fig. 3A) . Glucocorticoids enhance the stimulation of NHE3 by insulin (2) . This effect may be due to induction of SGK1 by glucocorticoids. Figure 3B shows induction of the SGK1 transcript by glucocorticoids but not by insulin or hypertonicity in OK cells. The glucocorticoid-induced increase in the SGK1 transcript also leads to an increase in SGK1 protein, although less prominently than the SGK1 transcript (Fig. 3C) . Insulin alone has no effect on SGK1 transcript or protein abundance (data not shown). Serine 78 in SGK1 has been shown to become phosphorylated in response to growth factors (25) . Both acute (2 h) and chronic (24 h) treatment with insulin lead to increased phosphorylation of SGK1 on serine 78 (Fig. 3D) .
Effect of insulin on NHE3 phosphorylation. We previously showed that insulin activates NHE3 transport activity within 2 h of application with mechanisms that are distinct from the more chronic effects (31) . We explored several potential mechanisms by which this could occur. Changes in NHE3 activity independent of alterations in cell surface NHE3 have been described with several agonists, where changes in NHE3 phosphorylation were postulated to modulate the intrinsic activity of the transporter (60) . Insulin has no effect on whole protein phosphorylation of NHE3 (Fig. 4A) . Since NHE3 is a multiphosphorylated protein and changes in single phosphorylated sites may not be evident in a whole phosphoprotein assay, we proceeded to examine individual phosphoaminoacid residues with tryptic phosphopeptide mapping. Figure 4B shows that there is no discernible difference in individual NHE3 phosphorylation sites with acute insulin treatment (10 Ϫ6 M, 2 h) or when glucocorticoid in conjunction with insulin was applied (10 Ϫ6 M each, 2 h). The two-dimensional profile of the tryptic phosphopeptide map is identical to that previously described for native NHE3 in OK cells (62) . In clear contradistinction to hormones coupled to protein kinase A, insulin and glucocorticoids therefore acutely alter NHE3 activity without changes in surface NHE3 protein (31) or NHE3 phosphorylation.
Signal transduction pathways of acute (2 h) effect of insulin on NHE3.
Insulin appears to regulate NHE3 via a biphasic mechanism (31) . While the chronic effect of insulin on NHE3 appears to proceed through the PI3K-SGK1 pathway, the signaling cascade for the acute effect is not known. We explored several possibilities. First, the PI3K-SGK1 pathway that mediates the chronic effect of insulin does not appear to be involved as neither PI3K nor SGK1 blockade affects the insulin effect (Fig. 5, A and B ). An alternative, but not mutually exclusive, pathway involves the cbl/CAP/TC10 complex that assembles in caveolae (15, 16, 57) . There is some evidence that NHE3 may be present and acutely regulated in these structures (37) . The dominant-negative form of the Rho-GTPase TC10 is effective in blocking this pathway (16) . We overexpressed dominant-negative and constitutively active TC10 to disrupt or activate this pathway, respectively. However, neither did affect the acute effect of insulin stimulation on NHE3 (Fig. 5C) . Akt was activated in OK cells after 2 h of treatment with insulin, Fig. 2 . Expression of SGK1 in the proximal tubule. A: rat renal cortex was fixed and stained with anti-SGK1 antibody. Specificity of staining was confirmed by blocking with immunogenic peptide (amino acids 399 -412 of human SGK1, GKSPDSV-LVTASVK; right). B: staining of SGK1 (green) and actin (red) in OK cells. C: rat proximal tubules were microdissected free of all attached tissues, and SGK1 transcript was detected by RT-PCR in proximal straight tubules (PST), proximal convoluted tubules (PCT), and cortical collecting duct (CCD). NHE3 transcript served as a control for microdissection quality. but dominant-negative Akt did not prevent insulin from stimulating NHE3 (Fig. 5D) .
Effect of acute insulin stimulation (2 h) on NHE3-associated proteins.
Another potential mechanism by which NHE3 can be regulated independently of changes in surface NHE3 protein or phosphorylation is by association with binding proteins. Biemesderfer and co-workers (7, 8) have proposed that association of brush-border NHE3 with megalin can provide a mechanism to regulate the resident pool of brush-border NHE3 transporters, and there are data from pathophysiological animal models compatible with this hypothesis (6) . We therefore tested whether insulin can alter the assembly between NHE3 and megalin. Figure 6A shows that insulin does not alter total surface NHE3 or the association of NHE3 with megalin at 2 h.
Type I adenosine receptor agonists can acutely change NHE3 activity without changes in cell surface NHE3 antigen, and this alteration is associated with and dependent on NHE3 binding with CHP (21). We next tested this possible mechanism in the acute insulin model. Figure 6B shows that insulin does not alter the amount of CHP in the NHE3 immune complex nor does it alter NHE3 or CHP phosphorylation.
DISCUSSION
The role of insulin in proximal tubule function is important for Na ϩ and acid-base homeostasis. A pathogenic role has been proposed for chronic insulin-stimulated Na ϩ absorption causing volume expansion and hypertension in type II diabetes mellitus and the metabolic syndrome (50) , but this conjecture has been countered by others (24) . The direct antinatriuretic action of insulin has been shown in the proximal tubule (4) and thick ascending limb (30) . In addition to Na ϩ absorption, insulin also stimulates ammoniagenic enzymes in the proximal tubule. Since NHE3 is the key mediator for ammonium excretion into the proximal tubule lumen (43) , the physiological significance of stimulation of NHE3 activity by insulin may be germane to the provision of a urinary buffer for H ϩ excretion. Impairment of the ammoniagenic response to insulin has been proposed to cause uric acid stone formation in subjects with insulin resistance (40) . Understanding the signaling pathway between insulin and NHE3 is therefore of great pathophysiological importance.
There are four key findings in the present study. First, the chronic effect of insulin on NHE3 appears to depend on the classic PI3K-SGK1 cascade. Second, the enhancement of the insulin effect by glucocorticoids can be partially explained by increased SGK1 expression. Third, neither insulin nor glucocorticoids alters NHE3 activity by a change in its phosphorylation status. Fourth, the acute stimulation of NHE3 by insulin does not involve any of the known mechanisms of insulin signaling or NHE3 regulation.
While SGK1 transcript was found in the proximal tubule (38) , expression of SGK1 protein in the proximal tubule is less clear from the literature. We definitively show expression of SGK1 transcript and protein in the proximal tubule and a proximal tubule-like cell line. For our cell culture studies using OK cells, we cloned and sequenced opossum (D. virginiana) SGK1. Pharmacological inhibition of PI3K and dominantnegative inhibition of SGK1 blocked the effect of insulin on NHE3 activity. The small residual effect of insulin on NHE3 activity with transfection-based techniques can be accounted for by the Ͻ100% transfection efficiency. Note that overexpression of SGK1 per se did not increase baseline NHE3 activity in the absence of other agonists. This suggests that SGK1 overexpression or activation is necessary but not sufficient to stimulate NHE3 activity. Insulin possibly activates parallel cascades in addition to PI3K-SGK1 activation to effect the stimulation of NHE3.
Of note, basal NHE3 activity was reduced by the PI3K inhibitor wortmannin in the acute (2 h) experiments but was not changed in the chronic (24 h) experiments. The insulinstimulated NHE3 activity was significantly reduced by wortmannin after 24 h, indicating that wortmannin was still active at that time point. The short-term effect of wortmannin on basal NHE3 activity is in accordance with previous studies in OK cells (1) and in AP-1 cells transfected with NHE3 (34) . The lack of effect with the longer incubation time is difficult to speculate on, but this could be due at least in part to an 32 P]orthophosphate pulse, cells were then treated with insulin (10 Ϫ6 M, 2 h) or vehicle, and native NHE3 was immunoprecipitated, resolved on SDS-PAGE, and analyzed with immunoblotting and autoradiography. The phospho-NHE3 signals were compared with total NHE3 antigen. Bars and errors bars represent means and SE, respectively; n ϭ 9 for each condition. B: for separate visualization of individual phosphorylation sites, 32 P-labeled native NHE3 isolated by immunoprecipitation was proteolyzed with trypsin, and the tryptic peptides were resolved in 2 dimensions (electrophoresis and thin-layer chromatography) and imaged with autoradiography. Agonists were insulin (10 Ϫ6 M, 2 h, top) or combined hydrocortisone and insulin (each 10 Ϫ6 M, 2 h, bottom); n ϭ 3 for each condition.
"escape" mechanism of the baseline endosomal recycling machinery.
Glucocorticoids have been shown to exert a permissive effect on the adaptation of NHE3 to metabolic acidosis in both animals (29) and cell culture (2) . We have shown that glucocorticoids enhance the insulin effect on NHE3 even in concentrations where glucocorticoids alone have no effect (31) . We showed that glucocorticoids increase SGK1 transcript and protein in a proximal tubule-like cell line. The current body of data does not prove that SGK1 activation mediates the enhancing effect of glucocorticoids. However, the fact that overexpression of SGK1 by transfection also enhances the insulin effect is in keeping with this model.
Regulation of NHE3 activity is extremely complex, with an ever-expanding list of mechanisms involving transcription, protein synthesis, trafficking, and yet unidentified mechanisms of altering transporter activity. Changes in NHE3 activity without changes in plasma membrane NHE3 have been described with acute activation of protein kinase A by permeant cAMP analogs or Gs-coupled peptide hormones (41) . In all these instances, NHE3 was phosphorylated on multiple serine residues by protein kinase A (35, 62) . Since insulin signaling involves multiple kinases, we examined for this possibility but did not find any changes in NHE3 phosphorylation in any sites associated with treatment with insulin or glucocorticoids. Acute activation of the adenosine A 1 receptor also changes NHE3 activity independently of NHE3 phosphorylation or changes in NHE3 surface protein (21) . This effect was associated with and required interaction of NHE3 with CHP (21) . Acute treatment with insulin, however, did not alter NHE3-CHP association in the NHE3 immune complex nor did it change CHP phosphorylation.
The classic IRS-PI3K-PDK-Akt pathway is not unique. Saltiel and others (15, 16, 57) have described a parallel path- A: OK cells were treated with insulin (10 Ϫ6 M, 2 or 24 h) or vehicle, and total cell surface and cell surface megalin-associated NHE3 were assayed as described in EXPERIMENTAL PROCEDURES. B: effect of insulin on NHE3 phosphorylation, NHE3-calcineurin homologous protein (CHP) association, and phosphorylation of the NHE3-associated CHP. After cotransfection with NHE3 and CHP, quiescent OK cells were treated with insulin (10 Ϫ6 M, 2 h) after a [ 32 P]orthophosphate pulse, and CHP was coimmunoprecipitated with NHE3. NHE3 and CHP phosphorylation and antigen in the immune complex were then analyzed by autoradiography and immunoblotting, respectively; n ϭ 6 for each condition.
way that involves the cbl/CAP/TC10 complex. We explored the contribution of the TC10 pathway but could not block the insulin effect with overexpression of the dominant-negative TC10. This may indicate that TC10 is not involved in the signaling between insulin and NHE3, or that another member of the Rho-GTPase family that is not affected by dominantnegative TC10 is present in OK cells.
In summary, we characterized the effect of insulin on proximal tubule NHE3 regulation and showed that the chronic effect is via the conventional PI3K-SGK1 pathway. We attempted to study the acute effect of insulin and managed to exclude the known mechanisms and signaling pathways.
